Any RBL news yet?!?!

Discussion in 'Sanofi' started by anonymous, Jan 19, 2018 at 12:08 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Is that Republican math!? With you predictions...that’s a bit more than 400 people!
     

  2. anonymous

    anonymous Guest

    It will be. Sanofi projected layoff numbers are always higher. Buckle up ! Tell your family the Grim Reaper is coming next week. You were warned for well over 9 months this was coming. If you had your head in the sand and thought everything will be fine - well good luck
     
  3. anonymous

    anonymous Guest

    The number that has been going around is precisely that, about 400 positions. All we have heard for months is that larger territories were coming and significant cuts to diabetes were on the horizon. If the RBL numbers have been reduced from 25 to 11, that would confirm (rough math) a doubling in geography covered.

    No need to guess as we will all know for sure very soon, but so far this seems consistent with the more credible rumors. Face it, you don't need as much sales coverage when the market is shifting to formulary driven prescribing and large areas filled with no-see offices. This is 2018, not 1998.
     
  4. anonymous

    anonymous Guest

    Fierce Pharma Sanofi news look it up
     
  5. anonymous

    anonymous Guest

    In 2012 layoff, they hoped 400 would take early retirement and only 200 did
     
  6. anonymous

    anonymous Guest


    What you're forgetting is there were FAR fewer openings in the higher paid RBL and ABL positions, while there are entire territories without 1 pcp 1-4 rep. I'm not saying that certain teams that are full won't see a 50% reduction is salesforce, but we've heard that the PC1s nationwide are at a 50% staffing rate anyway due to attrition, etc.

    If I had to guess, I would say you are looking at at least 150 to 200 RBL/ABL/Hospital/LTC cuts alone. That leaves about 200 to 250 rep positions gone, and there are A LOT more reps left than 4 to 500 hundred. If you remember the structure when we realigned last year, PC1-4 each had around 312 reps PER SALES TEAM nationwide, making 1250 pcp positions alone. Then add specialty at around 216 positions (approx...and just diabetes specialty), you are looking at around 1475 reps (not including CV specialty, who I believe will remain untouched in this), if ALL positions were full. Let's even say there's a 60% attrition or opening rate out of 1475 (which could be high), that still leaves about 590 reps. My guess, field sales is looking at more like a 1 out of 3 reduction vs 1 out of 2. I could be wrong...but there may be more left than we think.....management and LTC/Hospital will definitely take the higher percent reduction, IMO.
     
  7. anonymous

    anonymous Guest

    I think a lot will depend on how you count. Are open positions that will now go unfilled forever counted as a cut? If an ABL accepts a reduction in title back to sales rep and another sales rep is displaced because of that action is it a sales force reduction or an ABL reduction? I think we just have to wait until the end of next week and see the results.
     
  8. anonymous

    anonymous Guest

    Dwayne, it's "Basaglar" not "Basaglare" dude.
     
  9. anonymous

    anonymous Guest

    We know from prior cuts that any number they give us (in this case 50% cut) that will be on top of whatever vacancies there are.

    Remember 2 years ago? We all thought we were safe b/c they said "30% cut" & we had nearly a 40% vacancy at that time so... We were good. But in actuality, they cut 30% more than the vacancies. They shit canned 30% of us the week before Christmas & then moved the remaining reps to new teams & new territorries that were so illogical it was maddening.

    The sales force never recovered from the outright lies from management & the complete lack of logic in the new alignments. Sales leadership sabotaged us & then they've acted as though they're in shock that sales have missed projections.

    I assure you that whatever is coming will be a lot worse than what we've been told.
     
  10. anonymous

    anonymous Guest

    Let me tell you he is way too good for Sanofi regardless of how he pronounces a drug. Nice, smart, professional.
     
  11. anonymous

    anonymous Guest

    Agreed , Dwayne was a great guy.
     
  12. anonymous

    anonymous Guest

    Totally agree. He was the best at that level this company has seen in a long time.
     
  13. anonymous

    anonymous Guest

    Or as the managed care people call it "that stuff that is way cheaper than Lantus".
     
  14. anonymous

    anonymous Guest

    Dwayne actually listened to his reps. He also came into the field and saw things first-hand.

    I would work for him again.
     
  15. anonymous

    anonymous Guest

    Dwayne started in April. He was here 9 months. What the hell was this company thinking hiring ANYONE for ANY sales position in 2017??? We all knew this was coming. I'm sure he was fed a great line by BW in the interviews, how he could turn Ohio around for the next few years, blah blah blah.

    Sometimes I think they hire people just to see them let go within a few months or simply to keep them from working for REAL companies within the industry to sell against their products. What a joke.
     
  16. anonymous

    anonymous Guest

    LTC and HOspital were gone last Friday at 2 pm. This next week will be a bloodbath . 50% of ABL's in Diabetes will be gone . CV Specialty untouched except in RBL and ABL. RBL's in CV already found out their fate lasts Friday - only 2 for country survived. The ABL's cut will be huge on Tuesday and reps in Diabetes will find out Thursday . This will be huge. Good luck to all. If you didn't take early retirement than extra good luck.
     
  17. anonymous

    anonymous Guest

    How many hospital and LTC reps were there?
     
  18. anonymous

    anonymous Guest

    Remember the RBL layoff was easy . This team has the lowest talent in the company and the reduction won't be felt at the sales level . All let go will land at Office Depot or at Piggly Wiggly. The ones that survived was due to the Peter Principle that Sanofi works off of. The CV pool is extremely weak and the survivors were not the best.
     
  19. anonymous

    anonymous Guest

    Yes agree very nice man. He was an actual human being not a psychopath. I am not sure why but that particular job title seems to attract the absolute worst people , at least at Sanofi. I wish I had video cam from my field visits with RBL's here over the years. I mean CRAZY. I even had one that cried.
     
  20. anonymous

    anonymous Guest

    Why do they keep saying they are going to make the territories more manageable? This has to be for the specialty reps, as a lot of the pcp near me are pretty manageable already. Plus, they have to go back to having 2 specialty overlap 2 or 3 pods, like pre 2017. There is no way they can have 2 specialty per territory, plus 2 pcp per territory, unless they territories get huge for pcp reps! And if that's the case, then that goes against making them manageable. I don't get it...talk about as clear as mud.